A cost-effectiveness analysis of COVID-19 critical care interventions in Addis Ababa, Ethiopia: a modeling study

Table 1 Probability and cost (USD 2021) used for the cost- effectiveness analyses model

Probability data	Base value	Range	Dis^a	Data source
Well person to Critical	0.05	0.04–0.06	Beta	[4]
Well person to Severe	0.15	0.12–0.18	Beta	[4]
Well person to MIMO	0.8	0.64–0.96	Beta	[4]
Mortality from invasive case	0.30	0.5–0.8	Beta	[18]
Disability weight of COVID-19 in mild/moderate	0.051	0.032–0.074	Beta	[27, 27]
Disability weight of COVID-19 in severe case	0.13	0.09–0.19	Beta	[19, 26]
Disability weight of COVID-19 in critical case	0.41	0.27–0.56	Beta	[19, 26]
COVID -19 death from MIMO	0.03	0.024–0.036	Beta	Primary
COVID-19 death from Severe	0.12	0.096–0.14	Beta	Primary
COVID -19 death from invasive	0.97	0.89–0.99	Beta	Primary [17, 18]
COVID -19 death from none-invasive	0.33	0.264–0.396	Beta	Primary^[15]
COVID -19 recovery from severe	0.88	0.70–1	Beta	Primary
COVID -19 recovery from MIMO	0.97	0.776–1	Beta	Primary
COVID -19 recovery from invasive	0.02	0.016–0.024	Beta	Primary
COVID- 19 recovery from noninvasive	0.67	0.53–0.80	Beta	Primary
COVID- 19 cost for severe	3449	2759–4139	Gama	Primary
COVID -19 cost for noninvasive	5514	4411–6616	Gama	Primary
COVID -19 cost for invasive	6500	5200–7800	Gama	Primary
Discounting for costs and effectiveness	0.03	0.01–0.06	Beta	[28]
COVID 19 cost for mild/moderate	951	761–1142	Gama	Primary

ISSN: 1478-7547